Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q36729432

Q36729432

about

Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo Cytokeratin 18-associated Histone 3 Modulation in Hepatocellular Carcinoma: A Mini Review.Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt.Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.

P2860

Q36879787-8190CE86-1E86-45DC-858F-075180963FCA Q37607905-CF21837D-8549-469D-9B54-B4FD7C8EF321 Q37633285-3B372EAD-B6B6-46A3-894E-49BFED12B257 Q39396613-D6A634FB-2567-4C81-A417-173555E2EEAF Q47387460-FDAC18DA-1244-40E7-A60B-6E161F3146FD Q47869247-AE344A26-E582-4257-9683-2A4B96367544 Q52624664-9E589D31-84E3-4ACE-BC7A-5E336CE3B7A9

P2860

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q36729432

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@ast

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@en

type

Item

label

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@ast

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@en

prefLabel

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@ast

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@en

P1476

Novel histone deacetylase inhi ...... uman hepatocellular carcinoma.

@en

P2093

Che-Ming Teng

http://www.w3.org/2001/XMLSchema#string

Chin-Yu Lai

http://www.w3.org/2001/XMLSchema#string

Hui-Hsuan Huang

http://www.w3.org/2001/XMLSchema#string

Jing-Ping Liou

http://www.w3.org/2001/XMLSchema#string

Mei-Chuan Chen

http://www.w3.org/2001/XMLSchema#string

Mei-Jung Lai

http://www.w3.org/2001/XMLSchema#string

Yi-Jyun Lin

http://www.w3.org/2001/XMLSchema#string

Yu-Hsuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of death receptor signals by cellular FLIP

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009

Synthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivo

Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.

Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.

A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression

P304

402-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6352

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chia-Ron Yang

P577

2015-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284278789

http://www.w3.org/2001/XMLSchema#string

P698

26587975

http://www.w3.org/2001/XMLSchema#string

P932

4808007

http://www.w3.org/2001/XMLSchema#string

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.

about

P2860

P2860

Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932